Learn More
Invitrogen™ SARS Envelope Protein Polyclonal Antibody

Description
The immunogen is 100% (10/12) homologous to SARS-COV-2 (COVID-19) Envelop protein. The cross reactivity is not empirically tested. Suggested positive control: recombinant fusion protein. Immunogen sequence: YSRVKNLNSS EG.
Specifications
Specifications
| Antigen | SARS Envelope Protein |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.05% sodium azide |
| Gene Alias | Coronavirus; COVID; COVID 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS-CoV2; SARS-CoV-2; SARS-E |
| Host Species | Rabbit |
| Immunogen | Synthetic peptides corresponding to amino acids 59-70 of the putative SARS envelope protein. |
| Purification Method | Protein G |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.